List of redirects

Showing below up to 50 results in range #951 to #1,000.

951. ARMYDA-ACS → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes
952. ARMYDA-RECAPTURE → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Recapture
953. ARMYDA-RELOAD → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload
954. ARNT gene → Aryl hydrocarbon receptor nuclear translocator
955. ARPEGGIO → Rimonabant Improves Glycemic Control In Insulin-Treated Type 2 Diabetes
956. ARPKD → Polycystic kidney disease
957. ARR → Absolute risk reduction
958. ART → AIDS antiretroviral drugs
959. ARTIST → Angioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial
960. ARTISTIC → Angiorad Radiation Therapy For In-Stent Restenosis Intracoronary
961. ARTS → Arterial Revascularization Therapies Study
962. ARTS-II → Arterial Revascularization Therapies Study Part II: Sirolimus-Eluting Stents For The Treatment Of Patients With Multivessel De Novo Coronary Artery Lesions
963. ARTS I - Five year follow-up → Five Year Clinical Follow-Up Of The Arterial Revascularisation Therapy Study
964. ARVC → Arrhythmogenic right ventricular dysplasia
965. ARVD → Arrhythmogenic right ventricular dysplasia
966. ARVD/C → Arrhythmogenic right ventricular dysplasia
967. AR Deficiency → Androgen insensitivity syndrome
968. AR deficiency → Androgen insensitivity syndrome
969. ASA → Aspirin
970. ASAP → Effect Of Aggressive Versus Conventional Lipid Lowering On Atherosclerosis Progression In Familial Hypercholesterolemia
971. ASA physical status class → Conscious sedation#ASA Physical Status Classification
972. ASA physical status classification → Conscious sedation#ASA Physical Status Classification
973. ASCENT → Acs Stent Clinical Equivalence In De Novo Lesions Trial
974. ASCOT → Anglo-Scandinavian Cardiac Outcome Trial
975. ASCOT-LLA Trial → ASCOT-LLA
976. ASCOT - Blood Pressure Arm → Anglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm
977. ASCOT - Lipid Arm → ASCOT-LLA
978. ASCVD → CAD
979. ASD → Atrial septal defect
980. ASFAST → Atherosclerosis And Folic Acid Supplementation Trial
981. ASH → Hypertrophic cardiomyopathy
982. ASIS → Angina And Silent Ischemia Study
983. ASL (gene) → Argininosuccinate lyase
984. ASMA → Anti-SM antibody
985. ASO → Antistreptococcal antibodies
986. ASO titer → Antistreptolysin O titer
987. ASPAC → Asian-Pacific Collaboration On Chd Risk Factor Intervention
988. ASPA (gene) → Aspartoacylase
989. ASPECT-2 → Aspirin And Coumadin After Acute Coronary Syndromes (The Aspect-2) Study: A Randomised Controlled Trial.
990. ASPEN → ASPEN Trial
991. ASPEN trial → ASPEN Trial
992. ASPIRE → Arixtra Study In Percutaneous Coronary Intervention: A Randomized Evaluation
993. ASPM → ASPM (Genetics)
994. ASPSCR1 gene → ASPSCR1
995. ASRM → American Society of Reproductive Medicine
996. ASSENT-1 → Assessment Of The Safety Of A New Thrombolytic: Tnk-Tpa
997. ASSENT-2 → Assessment Of The Safety And Efficacy Of A New Thrombolytic: Tnk-Tpa-2
998. ASSENT-4 PCI → Assessment Of The Safety And Efficacy Of A New Treatment Strategy For Acute Myocardial Infarction
999. ASSENT 3 → The Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen (Assent)-3 Investigators. Efficacy And Safety Of Tenecteplase In Combination With Enoxaparin, Abciximab, Or Unfractionated Heparin: The Assent-3 Randomized Trial In Acute Mi
1000. ASSENT 3 PLUS → Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen-3